Join to View Full Profile
825 Eastlake Ave ESeattle, WA 98109
Phone+1 206-288-1000
Dr. Stirewalt is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of WashingtonFellowship, Medical Oncology, 1995 - 1999
University of North Carolina at Chapel Hill School of MedicineClass of 1992, MD
Certifications & Licensure
WA State Medical License 1996 - 2027
NC State Medical License 1995 - 1998
American Board of Internal Medicine Medical Oncology
Clinical Trials
- S9031-S9126-S9333-S9500-A, Studying Bone Marrow and Blood Samples From Patients With Acute Myeloid Leukemia Start of enrollment: 2008 Nov 01
- S9031-9333-0106-0112-A Study of Biomarkers in Samples From Patients With Acute Myeloid Leukemia Treated With Standard Chemotherapy With or Without Gemtuzumab Ozogamicin Start of enrollment: 2011 Dec 01
Publications & Presentations
PubMed
- Evaluation of acute myeloid leukemia using genomic proximity mapping-based next generation cytogenomics.Cecilia C S Yeung, Stephen M Eacker, Olga Sala-Torra, Mary Wood, Lan Beppu
Haematologica. 2026-01-15 - 1 citationsSF3B1K700E Neoantigen Is a CD8+ T-cell Target Shared across Human Myeloid Neoplasms.Melinda A Biernacki, Jessica Lok, Kimberly A Foster, Carrie Cummings, Stephanie Busch
Cancer Immunology Research. 2025-09-02 - 1 citationsCD34+ Cell Dose, Measurable Residual Disease, and Outcome After Myeloablative HLA-Matched Peripheral Blood Hematopoietic Cell Transplantation for Adults with Acute Mye...Margery Gang, Megan Othus, Anne-Chloe Olix, Kate A Markey, Derek L Stirewalt
Cancers. 2025-07-12
Journal Articles
- Second Cycle Remission Achievement with 7+3 and Survival in Adults with Newly Diagnosed Acute Myeloid Leukemia: Analysis of Recent SWOG TrialsBrent L Wood, Roland B Walter, John E Godwin, James K Weick, Elihu H Estey, Derek L Stirewalt, Frederick R Appelbaum, Nature
Grant Support
- Hematology Central Coordinating Center (HCCC) for the NIDDK Hematology Centers ProgramUNIVERSITY OF UTAH2020–2030
- Stem Cell and Transplantation BiologyFRED HUTCHINSON CANCER CENTER2015–2026
- Discovery And Optimization Of AML Prognostic BiomarkersNational Cancer Institute2012
- IRF8 As A Biomarker Of Aging, Malignant Transformation, And AML PrognosisNational Cancer Institute2010–2011
- Quantitative Rt/Pcr-Based Radiation DosimetryNational Institute Of Allergy And Infectious Diseases2005–2009
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
